HLB Co., Ltd.
028300
Peringkat dalam Saham
#4140
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Harga Saham
$29.28
Kapitalisasi Pasar
$3.89B
Perubahan (1 hari)
-1.40%
Perubahan (1 tahun)
-8.45%
Negara
KR
Perdagangan HLB Co., Ltd. (028300)
Kategori
Healthcare
Jumlah saham beredar untuk HLB Co., Ltd. (028300)
Jumlah saham beredar per June 2026: 132.90M
Menurut laporan keuangan terbaru dan harga saham HLB Co., Ltd., jumlah saham beredar saat ini adalah 132.90M. Pada akhir December 2023, perusahaan memiliki 121.24M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk HLB Co., Ltd. (028300) dari 2012 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 132.90M | 1.68% |
| 2024 | 130.70M | 7.81% |
| 2023 | 121.24M | 7.68% |
| 2022 | 112.59M | -6.32% |
| 2021 | 120.18M | -2.83% |
| 2020 | 123.68M | 22.11% |
| 2019 | 101.28M | 6.04% |
| 2018 | 95.51M | 4.49% |
| 2017 | 91.40M | 0.94% |
| 2016 | 90.55M | 7.76% |
| 2015 | 84.04M | 34.50% |
| 2014 | 62.48M | 7.44% |
| 2013 | 58.16M | 20.89% |
| 2012 | 48.11M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 253.90M | 91.04% |
US
|
|
| 396.00M | 197.96% |
US
|
|
| 478.91M | 260.35% |
AU
|
|
| 62.19M | -53.21% |
NL
|
|
| - | - |
CH
|
